Marie Vercruyssen Department : Hematology Marie.Vercruyssen [at] bordet.be Publications Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis. Authors : Massaro F, Meuleman N, Bron D, Vercruyssen M, Maerevoet M Year : 2022 Journal : Cancers (Basel) Adult T-cell leukaemia-lymphoma: Pathogeny and clinical recommendations. Authors : Vercruyssen M, Van den Broeke A, Salaroli A, Nguyen P, de Wind A, Meuleman N, Bron D Year : 2019 Journal : Belgian J Hematology Monoclonal gammopathy of undetermined significance : when and why to look for them ? Authors : Meuleman N, Vercruyssen M Year : 2018 Journal : Rev Med Brux Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation. Authors : Cilla N, Vercruyssen M, Ameye L, Paesmans M, de Wind A, Heimann P, Meuleman N, Bron D Year : 2018 Journal : Rev Med Brux Long-term follow-up of 2 patients treated with 90Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma. Authors : Golstein SC, Muylle K, Vercruyssen M, Spilleboudt C, de Wind A, Bron D Year : 2018 Journal : Eur J Haematol More publications »